学术探索
学术期刊
新闻热点
数据分析
智能评审

CURRENT CHEMOTHERAPY AND FUTURE-DIRECTIONS IN RESEARCH FOR THE TREATMENT OF ADVANCED HORMONE-REFRACTORY PROSTATE-CANCER

被引：53
作者：
KREIS, W
机构：
[1] Department of Medicine, North Shore University Hospital Cornell University Medical College, Manhasset, NY, 11030
来源：
CANCER INVESTIGATION | 1995年 / 13卷 / 03期
关键词：
D O I：
10.3109/07357909509094465
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：296 / 312
页数：17
相关论文
共 155 条
[121]   TRIMETREXATE IN PROSTATIC-CANCER - PRELIMINARY-OBSERVATIONS ON THE USE OF PROSTATE-SPECIFIC ANTIGEN AND ACID-PHOSPHATASE AS A MARKER IN MEASURABLE HORMONE-REFRACTORY DISEASE [J].
SCHER, HI ;
CURLEY, T ;
GELLER, N ;
ENGSTROM, C ;
DERSHAW, DD ;
LIN, SY ;
FITZPATRICK, K ;
NISSELBAUM, J ;
SCHWARTZ, M ;
BEZIRDJIAN, L ;
EISENBERGER, M .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) :1830-1838
[122]  
SCHER HI, 1987, ADENOCARCINOMA PROST, P197
[123]  
SCHER S, 1985, SEMIN UROL, V3, P329
[124]   NEUROSCIENCE PROJECTIONS TO CURRENT DEBATES IN EMOTION PSYCHOLOGY [J].
SCHERER, KR .
COGNITION & EMOTION, 1993, 7 (01) :1-41
[125]  
SCHMIDT J, 1993, P ASCO, V12, P230
[126]  
SCHMIDT JD, 1993, CANCER, V71, P1005, DOI 10.1002/1097-0142(19930201)71:3+<1005::AID-CNCR2820711418>3.0.CO
[127]  
2-I
[128]   ESTRAMUSTINE AND VINBLASTINE - USE OF PROSTATE SPECIFIC ANTIGEN AS A CLINICAL-TRIAL END-POINT FOR HORMONE REFRACTORY PROSTATIC-CANCER [J].
SEIDMAN, AD ;
SCHER, HI ;
PETRYLAK, D ;
DERSHAW, DD ;
CURLEY, T .
JOURNAL OF UROLOGY, 1992, 147 (03) :931-934
[129]  
SELLA A, 1992, 8TH MED C CHEM ATH G, P723
[130]  
SHALLY AV, 1972, VITAM HORM, V30, P83
78910111213141516